Epigenomics AG Share Price
Stocks
ECX
DE000A37FT41
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
07:03:22 27/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.8700 EUR | 0.00% |
|
0.00% | -3.33% |
| 09-03 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 763K 849K 704K 638K 1.19M 80.77M 1.21M 8.45M 3.35M 42.23M 3.19M 3.12M 134M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.73M 13.05M 10.82M 9.81M 18.34M 1.24B 18.57M 130M 51.56M 649M 48.98M 47.93M 2.06B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
76.6% | Yield 2024 * |
-
| Yield 2025 | - |
Deutsche Boerse AGEUR
| Markets | Quality | ||
|---|---|---|---|
Deutsche Boerse AG
| ECX | Delayed | |
Boerse Muenchen
| ECX | Real-time | |
|
Börse Stuttgart
| ECX | Delayed |
| Current month | -8.42% | ||
| 1 month | -8.42% | ||
| 3 months | -7.45% | ||
| 6 months | -6.95% | ||
| Current year | -3.33% |
| 1 week | 0.87 |  | 0.88 |
| 1 month | 0.87 | | 1.19 |
| Current year | 0.84 | | 1.56 |
| 1 year | 0.84 | | 1.59 |
| 3 years | 0.5 | | 3 |
| 5 years | 0.5 | | 20 |
| 10 years | 0.5 | | 1,187.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 31/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 28/02/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 31/05/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 04/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/12/22 | Buy | Chief Financial Officer | 2,000 | 0.0122% | ||
| 07/09/21 | Sell | Director | 7,790 | 0.0637% | ||
| 01/02/21 | Buy | Chairman | 6,355 | 0.1079% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -1.14% | -71.00% | 853K | |
| -3.10% | -3.43% | +36.29% | +67.69% | 65.28B | |
| +0.33% | +7.26% | +11.51% | +77.95% | 54.57B | |
| +0.16% | +3.69% | +8.39% | +101.27% | 53.59B | |
| -0.75% | +2.13% | +23.14% | +47.25% | 45.03B | |
| -1.30% | -1.11% | +17.77% | +120.71% | 42.17B | |
| +1.26% | +2.23% | +241.81% | +835.31% | 39.42B | |
| -0.74% | -4.84% | +14.53% | +44.45% | 32.71B | |
| -2.70% | -7.34% | +23.17% | +0.36% | 24.01B | |
| +1.11% | +17.90% | +56.87% | +47.78% | 26.5B | |
| Average | -0.57% | +1.78% | +43.23% | +127.18% | 38.33B | |
| Weighted average by Cap. | -0.72% | +1.72% | +45.16% | +148.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 26.71K 22.14K 20.07K 37.53K 2.54M 38K 266K 105K 1.33M 100K 98.07K 4.22M |
| Net income | -3.35M -3.73M -3.09M -2.8M -5.24M -355M -5.31M -37.11M -14.73M -186M -14M -13.7M -589M | -314K -349K -290K -263K -491K -33.24M -497K -3.48M -1.38M -17.38M -1.31M -1.28M -55.2M |
| Net Debt | 10.46M 11.64M 9.64M 8.74M 16.35M 1.11B 16.55M 116M 45.96M 579M 43.66M 42.72M 1.84B | 10.97M 12.21M 10.12M 9.17M 17.15M 1.16B 17.36M 121M 48.21M 607M 45.8M 44.81M 1.93B |
Employees
2
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/10/26 | €0.8700 | 0.00% | 0 |
| 26/10/26 | €0.8700 | 0.00% | 80 |
| 23/10/26 | €0.8700 | -1.14% | 30 |
| 22/10/26 | €0.8800 | +1.15% | 60 |
| 21/10/26 | €0.8700 | 0.00% | 0 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ECX Stock
Select your edition
All financial news and data tailored to specific country editions
